ANNOUNCEMENT: Skye Bioscience and Tautomer Bioscience Enter Exclusive License for Development and Sale of Cannabis Products for Chronic Pain and Other Indications in South Africa and Rest of Africa
Skye Bioscience Inc., a pharmaceutical company developing drugs targeting the endocannabinoid system, and Tautomer Bioscience (Pty) Limited ("Tautomer"), a privately-owned biopharmaceutical company focused on addressing unmet medical needs in oncology,…
Continue Reading
ANNOUNCEMENT: Skye Bioscience and Tautomer Bioscience Enter Exclusive License for Development and Sale of Cannabis Products for Chronic Pain and Other Indications in South Africa and Rest of Africa